Duncan McKechnie

EVP, Chief Commercial Officer, Vertex Pharmaceuticals.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 2, 2026Sold 1,541 shares at $519.00 of Vertex Pharmaceuticals²
Mar 11, 2026Sold 2,633 shares at $498.42 of Vertex Pharmaceuticals³
Mar 4, 2026Sold 2,437 shares at $475.30 of Vertex Pharmaceuticals⁴
Feb 25, 2026Sold 2,410 shares at $489.00 of Vertex Pharmaceuticals⁵
Feb 25, 2026Sold 2,500 shares at $486.35 of Vertex Pharmaceuticals⁵
Feb 24, 2026Shares withheld for tax 873 shares at $485.11 of Vertex Pharmaceuticals⁵
Feb 17, 2026Shares withheld for tax 1,148 shares at $483.75 of Vertex Pharmaceuticals⁶
Feb 17, 2026Granted 4,962 shares of Vertex Pharmaceuticals⁶
Feb 13, 2026Shares withheld for tax 2,283 shares at $487.76 of Vertex Pharmaceuticals⁷
Feb 10, 2026Shares withheld for tax 1,127 shares at $468.41 of Vertex Pharmaceuticals⁸
Jan 22, 2026Granted 2,080 shares of Vertex Pharmaceuticals⁹
Jan 22, 2026Granted 4,720 shares of Vertex Pharmaceuticals⁹

The numbers on this page point here. Each one links to the record it came from.